Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Recovery in indices continues with technology stocks leading the way

The FTSE 100, DAX 40 and Nasdaq 100 continue their ascents, boosted by stronger US and Asian equity markets, especially in the technology sector.

Source: Bloomberg

​FTSE 100 continues to rise despite 30-year high in UK CPI

The recovery in the FTSE 100 100 continues despite UK inflation increasing to a higher than expected 30-year high at 6.2% in February, up from 5.5% in January. The year-on-year retail price index came in as expected at 8.2% compared to 7.8% a month earlier.

The 25 February high at 7,564 remains in focus but is likely to act as resistance, if reached today. Once overcome, the way will be open for the February peak at 7,688.

Slips should find support along the 55-day simple moving average (SMA) at 7,436 and further down at the one-month support line at 7,385 as well as at the breached 2022 downtrend line at 7,364.

Source: ProRealTime

DAX 40 benefits from overnight rise in US and Asian stocks

The DAX 40 continues its advance, having so far risen by over 15% from its early March low, on the back of a rebound in US and Asian stocks overnight with the war in Ukraine taking a back seat in investors’ minds.

The 25 February high at 14,678 remains in focus, ahead of a key multi-year resistance area which sits between 14,840 and 14,917 and goes back to the May 2021. Because of inverse polarity, this area is likely to act as strong resistance.

Minor support below yesterday’s low at 14,233 can be spotted between Friday’s low and the previous Friday’s high at 14,106 to 14,102 with further support coming in at the 9 March 13,995 high and 16 March 13,927 low.

Source: ProRealTime

Nasdaq 100 leaves bottoming pattern to the upside

US stock futures continue to rally after last week reporting some of their biggest weekly gains since November 2020 with the Nasdaq 100 leaving a double bottom chart formation to the upside and heading towards the 200-day SMA, mid-January low and February highs at 15,133 to 15,164.

Friday’s daily and weekly chart close above the early March high at 14,395 means that a double bottom has been formed, the theoretical upside target of which could take the index all the way to 18,545.

This upside target consists of the distance between the current March low and the early March high, projected higher from the latter. It is valid as long as no slip below the 12,945 current March low is seen.

Support now comes in between the 55-day SMA at 14,430 and the mid-point of the double bottom chart formation at 14,395. Further minor support can be spotted at the 14,040 mid-February low.

Source: ProRealTime

Seize your opportunity

Deal on the world’s stock indices today.

  • Trade on rising or falling markets
  • Get one-point spreads on the FTSE 100
  • Unrivalled 24-hour pricing
Find out more

See opportunity on an index?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Try a risk-free trade
  • See whether your hunch pays off
Log in now

See opportunity on an index?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Get spreads from one point on the FTSE 100
  • Trade more 24-hour indices than any other provider
  • Analyse and deal seamlessly on smart, fast charts
Log in now

See opportunity on an index?

Don’t miss your chance. Log in to take your position.

Take advantage

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

<h3>How much does trading cost?</h3>
<h3>Find out about IG</h3>
<h3>Plan your trading</h3>

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.